14 completed. 14 Phase 2, 6 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 14 | Completed 14 |
| Phase 1 | 6 | Completed 6 |
| Phase 3 | 1 | Completed 1 |
Follow Safety: new trials by email Literature Review of Safety trials Research Report on Safety
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT Anlotinib - Locally Advanced Non-Small Cell Lung Cancer, Thoracic Radiotherapy | Phase 2 | Completed | JIANYANG WANG | 44 | 2024-01-01 | 2026-10-07 |
| A Study of GC101 TIL in Advanced Melanoma (BZ) GC101 TIL - Tumor Infiltrating Lymphocytes, Safety | Phase 1 / Phase 2 | Completed | Shanghai Juncell Therapeutics | 18 | 2023-11-08 | 2025-12-23 |
| Effect of Diuretics Withdrawal in Chronic Heart Failure With Reduced Ejection Fraction Diuretics withdrawal, Diuretics maintenance - Heart Failure, Electric Impedance | Phase 2 | Completed | Maimónides Biomedical Research Institute of Córdoba | 98 | 2022-12-19 | 2024-11-04 |
| A Clinical Study to Evaluate the Safety, Pharmacokinetic Profile and Efficacy of CU-20401 CU-20401 - Safety | Phase 1 / Phase 2 | Completed | Cutia Therapeutics(Wuxi)Co.,Ltd | 48 | 2022-02-27 | 2024-12-10 |
| Efficacy of Ivermectin in COVID-19 Ivermectin, Placebo - Safety, SARS-CoV2 Infection | Phase 1 / Phase 2 | Completed | Bangkok Metropolitan Administration Medical College and Vajira Hospital | 72 | 2021-09-01 | 2021-12-15 |
| Autologous Adipose Derived Stem Cells Transplantation in the Treatment of Keloids. Autologous adipose derived stem cells - Keloid, Autologus Adipose Derived Stem Cells | Phase 2 | Completed | Makerere University | 8 | 2021-03-01 | 2021-06-18 |
| EMaBS TB Vaccine Study ChAdOx185A, MVA85A, BCG - Safety, Immunogenicity | Phase 1 / Phase 2 | Completed | University of Oxford | 72 | 2019-07-01 | 2022-08-05 |
| A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Diabetes Placebo, XEN-D0501 - Efficacy, Safety | Phase 2 | Completed | Pila Pharma | 54 | 2019-02-25 | 2022-04-29 |
| Renoir: A Randomised, Double-blind, Controlled Trial to Evaluate the Effects of a New Human Milk Fortifier on Growth and Tolerance in Preterm Infants. Test product, Control product - Subjects in Need of a Human Milk Fortifier (HMF), Growth | Phase 2 / Phase 3 | Completed | Nutricia Research | 207 | 2018-03-08 | 2024-09-26 |
| Hodgkin Lymphoma Treatment With Adcetris and Levact in the Old Patient Adcetris-Levact - Clinical Efficacy, Safety | Phase 1 / Phase 2 | Completed | Centre Antoine Lacassagne | 60 | 2016-01-14 | 2026-08-31 |
| A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma 800 μg AZD7594 once daily, 250 µg AZD7594 once daily, 58 µg AZD7594 once daily - Asthma, Efficacy | Phase 2 | Completed | AstraZeneca | 54 | 2015-06-25 | 2018-02-15 |
| A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique HIVIS DNA vaccine, Zetajet, Derma Vax Electroporation - Vaccines, HIV | Phase 2 | Completed | Muhimbili University of Health and Allied Sciences | 198 | 2012-11-01 | 2015-06-29 |
| Study to Demonstrate the Safety of a Novel Powder Formulation of Lactobacilli in Adults Lactobacillus Reuteri DSM 17938 - Safety | Phase 1 / Phase 2 | Completed | Good Food Practice, Sweden | 32 | 2012-03-01 | 2012-07-04 |
| A Phase II Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants 160U /0.5ml EV71 Vaccine, 320U /0.5ml EV71 vaccine, 640U /0.5ml EV71 vaccine - Immunogenicity, Safety | Phase 2 | Completed | Jiangsu Province Centers for Disease Control and Prevention | 1200 | 2011-07-01 | 2012-05-31 |
Asthma (1) · COVID-19 (1) · Carcinoma, Non-Small-Cell Lung (1) · Diabetes Mellitus, Type 2 (1) · Drug-Related Side Effects and Adverse Reactions (1) · Dyspnea (1) · Edema (1) · Heart Failure (1) · Keloid (1) · Melanoma (1) · Tuberculosis (1)
Respiratory Tract Diseases (4) · Lung Diseases (3) · Infections (2) · Neoplasms (2) · Neoplasms by Site (2) · Pathological Conditions, Signs and Symptoms (2) · Skin and Connective Tissue Diseases (2) · Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Bronchial Diseases (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Cardiovascular Diseases (1) · Chemically-Induced Disorders (1)
Adjuvants, Pharmaceutic (1) · Albuterol (1) · Bendamustine Hydrochloride (1) · Brentuximab Vedotin (1) · Control Groups (1) · Ivermectin (1) · MVA 85A (1) · anlotinib (1) · smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic (1) · velsecorat (1)
AstraZeneca (1) · Bangkok Metropolitan Administration Medical College and Vajira Hospital (1) · Centre Antoine Lacassagne (1) · Cutia Therapeutics(Wuxi)Co.,Ltd (1) · Good Food Practice, Sweden (1) · JIANYANG WANG (1) · Jiangsu Province Centers for Disease Control and Prevention (1) · Maimónides Biomedical Research Institute of Córdoba (1) · Makerere University (1) · Muhimbili University of Health and Allied Sciences (1) · Nutricia Research (1) · Pila Pharma (1) · Shanghai Juncell Therapeutics (1) · University of Oxford (1)
China (4) · France (2) · Germany (2) · Uganda (2) · United Kingdom (2) · Bulgaria (1) · Lithuania (1) · Mozambique (1) · Netherlands (1) · Spain (1) · Sweden (1) · Tanzania (1) · Thailand (1)
Alberto Torres Zamudio, MD (1) · Andrea Ludwig-Sengpiel, Dr. (1) · Anne-Marie Kirsten, Dr. (1) · Anneliese Linnhoff, Dr. med. (1) · Christine Grigat, Dr. (1) · Dirk Skowasch, Prof. (1) · Dorte X Gram, PhD (1) · Helen McShane, Professor (1) · Johan Olsson, PhD (1) · Jun Guo (1) · Jutta Beier, Dr. med. (1) · Margret Jandl, Dr. (1) · Oliver Kornmann, Dr. (1) · Rainard Fuhr, Dr. med. (1)
PMID 21791539, PMID 23352749, PMID 25176015, PMID 28390780, PMID 30121146, PMID 30741494, PMID 30777086, PMID 31424503, PMID 32171764, PMID 32673497, PMID 33736819, PMID 34447992, PMID 36028897, PMID 40037774, PMID 42644287, PMID 42648772
2014 (1), 2018 (1)